The UK OFT issues statement of objections to certain pharmaceutical companies alleging they acted to delay effective competition in the UK supply of medicine (GSK / GUK / Alpharma / IVAX)

Brief, European Competition Network

Previous article The UK OFT issues a statement of objections to four pharmaceutical manufacturers for anticompetitive agreements over the supply of paroxetine (GSK / GUK / Alpharma / IVAX) Next article The EU Commission sends statements of objections to two pharmaceutical companies over a possible delayed entry of a generic pain-killer (Johnson & Johnson / Novartis)

19 Apr 2013

The UK OFT issues statement of objections to certain pharmaceutical companies alleging they acted to delay effective competition in the UK supply of medicine (GSK / GUK / Alpharma / IVAX)

KEYWORDS

Reference

UK OFT, Statement of Objections in Case involving Pharmaceutical Companies, Press release, 19 April 2013

United Kingdom: The OFT issues Statement of Objections in Case involving Pharmaceutical Companies* On 19 April 2013, the Office of Fair Trading (OFT) issued a Statement of Objections to certain pharmaceutical companies alleging

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

European Competition Network Brief
European Commission

Belgium 714 contributions 215667 visits

Quotation

European Competition Network Brief, The UK OFT issues statement of objections to certain pharmaceutical companies alleging they acted to delay effective competition in the UK supply of medicine (GSK / GUK / Alpharma / IVAX), 19 April 2013, e-Competitions Pay-for-delay agreements, Art. N° 53273

Visites 206